scholarly journals Interstitial Deletion of 2q22.2q22.3 Involving the Entire ZEB2 Gene in a Case of Mowat-Wilson Syndrome

2021 ◽  
pp. 1-9
Author(s):  
Khaled Refaat ◽  
Nivine Helmy ◽  
Mohamed Elawady ◽  
Mona El Ruby ◽  
Alaa Kamel ◽  
...  
Keyword(s):  
Congenital Heart ◽  
Autosomal Dominant ◽  
De Novo ◽  
Pulmonary Arteries ◽  
Hirschsprung Disease ◽  
Research Centre ◽  
Chromosomal Microarray ◽  
Facial Dysmorphism ◽  
Dysmorphic Features ◽  
Human Cytogenetics

Mowat-Wilson syndrome (MWS) is a rare autosomal dominant syndrome characterized by dysmorphic features, mental retardation, and congenital heart disease (CHD). MWS results from microdeletions of chromosome 2q23 or de novo SNVs involving the ZEB2 gene. Here, we report on an Egyptian MWS patient diagnosed by chromosomal microarray (CMA). A 1-year-old male child was referred to the CHD clinic, National Research Centre, presenting with dysmorphic features and CHD. The patient was referred to the human cytogenetics department for cytogenetic analysis and for screening of subtelomere rearrangements and microdeletion loci, using MLPA, and all revealed normal results. CMA revealed an interstitial 2.27-Mb microdeletion in chromosome 2q, involving the entire ZEB2 gene and other genes. This study emphasizes the significance of CMA in the detection of microdeletions/microduplications and as a screening tool in cases presenting with CHD and extracardiac manifestations. MWS should be suspected in patients presenting with the characteristic facial dysmorphism, developmental delay, seizures, Hirschsprung disease, and congenital heart anomalies, especially those involving the pulmonary arteries or pulmonary valves. It is recommended to include the ZEB2 locus in the MLPA microdeletions probes.

scholarly journals Acute pre-B lymphoblastic leukemia and congenital anomalies in a child with a de novo 22q11.1q11.22 duplication

2018 ◽  
Vol 21 (1) ◽  
pp. 87-91 ◽  
Author(s):  
M Vaisvilas ◽  
V Dirse ◽  
B Aleksiuniene ◽  
I Tamuliene ◽  
L Cimbalistiene ◽  
...  
Keyword(s):  
Congenital Heart ◽  
De Novo ◽  
Heart Defects ◽  
Lymphoblastic Leukemia ◽  
Snp Array ◽  
Facial Dysmorphism ◽  
Severe Intellectual Disability ◽  
Leukemic Clone ◽  
Cell Growth And Differentiation ◽  
Facial Dysmorphia

Abstract Microdeletions and microduplications are recurrent in the q11.2 region of chromosome 22. The 22q11.2 duplication syndrome is an extremely variable disorder with a phenotype ranging from severe intellectual disability, facial dysmorphism, heart defects, and urogenital abnormalities to very mild symptoms. Both benign and malignant hematological entities are rare. A male patient was diagnosed with mild facial dysmorphia, congenital heart anomalies shortly after birth and acute bowel obstruction due to malrotation of the intestine at the age of 3 years. A whole-genome single nucleotide polymorphism (SNP) array revealed a de novo 6.6 Mb duplication in the 22q11.1q11.22 chromosomal region. A year later, the patient was diagnosed with acute pre-B lymphoblastic leukemia (pre-B ALL). Five genes, CDC45, CLTCL1, DGCR2, GP1BB and SEPT5, in the 22q11.1q11.22 region are potentially responsible for cell cycle division. We hypothesized that dosage imbalance of genes implicated in the rearrangement could have disrupted the balance between cell growth and differentiation and played a role in the initiation of malignancy with a hyperdiploid leukemic clone, whereas over-expression of the TBX1 gene might have been responsible for congenital heart defects and mild facial dysmorphia.

A de novo 1q22q23.1 Interstitial Microdeletion in a Girl with Intellectual Disability and Multiple Congenital Anomalies Including Congenital Heart Defect

2018 ◽  
Vol 154 (1) ◽  
pp. 6-11 ◽  
Author(s):  
Beata Aleksiūnienė ◽  
Egle Preiksaitiene ◽  
Aušra Morkūnienė ◽  
Laima Ambrozaitytė ◽  
Algirdas Utkus
Keyword(s):  
Intellectual Disability ◽  
Congenital Heart Defect ◽  
Congenital Heart ◽  
De Novo ◽  
Molecular Karyotyping ◽  
Pcr Analysis ◽  
Chromosomal Microarray ◽  
Chromosomal Microarray Analysis ◽  
Protein Coding ◽  
Heart Defect

Many studies have shown that molecular karyotyping is an effective diagnostic tool in individuals with developmental delay/intellectual disability. We report on a de novo interstitial 1q22q23.1 microdeletion, 1.6 Mb in size, detected in a patient with short stature, microcephaly, hypoplastic corpus callosum, cleft palate, minor facial anomalies, congenital heart defect, camptodactyly of the 4-5th fingers, and intellectual disability. Chromosomal microarray analysis revealed a 1.6-Mb deletion in the 1q22q23.1 region, arr[GRCh37] 1q22q23.1(155630752_157193893)×1. Real-time PCR analysis confirmed its de novo origin. The deleted region encompasses 50 protein-coding genes, including the morbid genes APOA1BP, ARHGEF2, LAMTOR2, LMNA, NTRK1, PRCC, RIT1, SEMA4A, and YY1AP1. Although the unique phenotype observed in our patient can arise from the haploinsufficiency of the dosage-sensitive LMNA gene, the dosage imbalance of other genes implicated in the rearrangement could also contribute to the phenotype. Further studies are required for the delineation of the phenotype associated with this rare chromosomal alteration and elucidation of the critical genes for manifestation of the specific clinical features.

scholarly journals New case of Baraitzer-Winter Cerebrofrontofacial syndrome due to p.Ile136Val mutation in ACTB gene

2019 ◽  
pp. 44-50
Author(s):  
А.А. Гусина ◽  
С. Л. Куликова ◽  
В.Д. Кулак ◽  
Н.Б. Гусина
Keyword(s):  
Autosomal Dominant ◽  
De Novo ◽  
Direct Sequencing ◽  
Gene Sequencing ◽  
Hereditary Disease ◽  
Facial Dysmorphism ◽  
Missense Mutations ◽  
Healthy Siblings ◽  
Almost All ◽  
The Brain

Введение. Синдром Барайтсера-Винтера (BWCFF) - очень редкое аутосомно-доминантное наследственное заболевание, обусловленное мутациями в генах ACTB и ACTG1. Практически все известные случаи этого заболевания обусловлены миссенс-мутациями в генах ACTB и ACTG1, возникшими de novo. В этой работе представлен новый случай синдрома BWCFF, обусловленный мутацией p.Ile136Val в гене ACTB. Пациенты и методы. Пробанд - мальчик 6 лет 8 месяцев, из двойни. Фенотип пациента анализировали с использованием приложения Face2Gene. Пробанду и всем членам его семьи проведено секвенирование 1-4 экзонов и прилежащих интронных последовательностей гена ACTB. Результаты. У пробанда отмечены характерные симптомы BWCFF: постнатальная пограничная микроцефалия, специфические дизморфии, колобомы радужной оболочки обоих глаз, короткая шея с крыловидными складками, эпилепсия, врожденный порок сердца. В отличие от большинства случаев синдрома у пациента отсутствовали задержка интеллектуального развития, а также грубые изменения коры или других структур головного мозга. В результате секвенирования экзонов гена АСТВ у пациента была выявлена замена с.406A>G (p.Ile136Val, rs1554329352) в гетерозиготном состоянии. У родителей пробанда и здоровых сибсов мутация не была обнаружена. Заключение. Использование современных технологий фенотипирования позволило предположить клинический диагноз, провести эффективный целенаправленный поиск мутаций в гене ACTB и диагностировать новый случай синдрома BWCFF. Introduction Baraitser-Winter Syndrome (BWCFF) is a very rare autosomal dominant hereditary disease caused by mutations in the ACTB and ACTG1 genes. Almost all known cases of this disease are caused by de novo missense mutations in the ACTB and ACTG1. In this paper we present a new case of BWCFF syndrome, due to p.Ile136Val mutation in the ACTB gene. Patients and methods. Proband - a boy, 6 years 8 months, out of twins. The patient’s phenotype was analyzed using the Face2Gene application. Direct sequencing of 1-4 exons and the adjacent intron sequences of the ACTB gene was performed in proband and all members of his family. Results. The proband has characteristic symptoms of BWCFF: postnatal borderline microcephaly, facial dysmorphism, iris colobomas of both eyes, short, webbed neck, epilepsy, congenital heart defect. Unlike most cases of the syndrome the patient does not have developmental delay and gross changes in the cortex or other structures of the brain. ACTB gene sequencing resulted in detection of heterozygous missense mutation p.406A> G (p.Ile136Val, rs1554329352) in proband. This mutation was not found in his parents and healthy siblings. Conclusion The use of modern phenotyping technologies allowed us to suggest the correct clinical diagnosis, to conduct an effective targeted search for mutations in the ACTB gene and diagnose a new case of BWCFF syndrome.

scholarly journals Multiple Coronary Artery Microfistulas in a Girl with Kleefstra Syndrome

2016 ◽  
Vol 2016 ◽  
pp. 1-5
Author(s):  
Euthymia Vargiami ◽  
Athina Ververi ◽  
Hamda Al-Mutawa ◽  
Georgia Gioula ◽  
Spyridon Gerou ◽  
...  
Keyword(s):  
Coronary Artery ◽  
Developmental Delay ◽  
Congenital Heart Defects ◽  
Congenital Heart ◽  
De Novo ◽  
Heart Defects ◽  
Dysmorphic Features ◽  
Kleefstra Syndrome

Kleefstra syndrome is characterized by hypotonia, developmental delay, dysmorphic features, congenital heart defects, and so forth. It is caused by 9q34.3 microdeletions orEHMT1mutations. Herein a 20-month-old girl with Kleefstra syndrome, due to a de novo subterminal deletion, is described. She exhibits a rare and complex cardiopathy, encompassing multiple coronary artery microfistulas, VSD/ASD, and PFO.

scholarly journals 239-kb Microdeletion Spanning KMT2E in a Child with Developmental Delay: Further Delineation of the Phenotype

2021 ◽  
pp. 1-6
Author(s):  
Konstantina Kosma ◽  
Konstantinos Varvagiannis ◽  
Anastasios Mitrakos ◽  
Maria Tsipi ◽  
Joanne Traeger-Synodinos ◽  
...  
Keyword(s):  
Developmental Delay ◽  
De Novo ◽  
Neurodevelopmental Disorder ◽  
Dominant Negative ◽  
Dominant Negative Effect ◽  
Chromosomal Microarray ◽  
Global Developmental Delay ◽  
Common Mechanism ◽  
Facial Dysmorphism ◽  
Gi Symptoms

Pathogenic <i>KMT2E</i> variants underly O&apos;Donnell-Luria-Rodan syndrome, a recently described neurodevelopmental disorder characterized by global developmental delay, variable degrees of intellectual disability, and subtle facial dysmorphism. Less common findings include autism, seizures, gastrointestinal (GI) problems, and abnormal head circumference. Occurrence of mostly truncating variants as well as the similar phenotype observed in individuals with deletions spanning <i>KMT2E</i> suggest haploinsufficiency of this gene as a common mechanism for the disorder, while a gain-of-function or dominant-negative effect cannot be ruled out for some missense variants. Deletions reported in the literature encompass several additional known or presumed haploinsufficient genes, thus leading to more complex phenotypes. Here, we describe a male with antenatal onset hydronephrosis, hypotonia, global developmental delay, prominent GI symptoms as well as facial dysmorphism. Chromosomal microarray revealed a 239-kb de novo microdeletion spanning <i>KMT2E</i> and <i>LHFPL3</i>. Clinical presentation of our proband, harboring one of the smallest deletions of the region confirms the core features of this disorder, suggests GI symptoms as a prominent finding in affected individuals while expanding the phenotypic spectrum to abnormalities of the urinary tract.

scholarly journals De NovoTrisomy 1q10q23.3 Mosaicism Causes Microcephaly, Severe Developmental Delay, and Facial Dysmorphic Features but No Cardiac Anomalies

2016 ◽  
Vol 2016 ◽  
pp. 1-5
Author(s):  
Shirley Lo-A-Njoe ◽  
Lars T. van der Veken ◽  
Clementien Vermont ◽  
Louise Rafael-Croes ◽  
Vincent Keizer ◽  
...  
Keyword(s):  
Congenital Heart ◽  
De Novo ◽  
Chromosomal Abnormalities ◽  
Short Life ◽  
Cardiac Anomalies ◽  
Chromosome 1Q ◽  
Dysmorphic Features ◽  
Postnatal Diagnosis ◽  
Short Life Expectancy ◽  
Mosaic Trisomy

Proximal duplications of chromosome 1q are rare chromosomal abnormalities. Most patients with this condition present with neurological, urogenital, and congenital heart disease and short life expectancy. Mosaicism for trisomy 1q10q23.3 has only been reported once in the literature. Here we discuss a second case: a girl with a postnatal diagnosis of ade novopure mosaic trisomy 1q1023.3 who has no urogenital or cardiac anomalies.

scholarly journals Schinzel-Giedion Syndrome with Congenital Megacalycosis in a Turkish Patient: Report of SETBP1 Mutation and Literature Review of the Clinical Features

2017 ◽  
Vol 2017 ◽  
pp. 1-4
Author(s):  
Ozgul Bulut ◽  
Zeynep Ince ◽  
Umut Altunoglu ◽  
Sukran Yildirim ◽  
Asuman Coban
Keyword(s):  
Literature Review ◽  
Autosomal Dominant ◽  
De Novo ◽  
Facial Dysmorphism ◽  
Multiple Congenital Anomalies ◽  
Patient Report ◽  
Autosomal Dominant Disorder ◽  
Turkish Patient ◽  
Increased Risk ◽  
Risk Of Malignancy

Schinzel-Giedion syndrome (SGS) is a rare autosomal dominant disorder that results in facial dysmorphism, multiple congenital anomalies, and an increased risk of malignancy. Recently, using exome sequencing, de novo heterozygous mutations in the SETBP1 gene have been identified in patients with SGS. Most affected individuals do not survive after childhood because of the severity of this disorder. Here, we report SETBP1 mutation confirmed by molecular analysis in a case of SGS with congenital megacalycosis.

scholarly journals A Recurrent De Novo Terminal Duplication of 14q32 in Korean Siblings Associated with Developmental Delay and Intellectual Disability, Growth Retardation, Facial Dysmorphism, and Cerebral Infarction: A Case Report and Literature Review

Genes ◽  
2021 ◽  
Vol 12 (9) ◽  
pp. 1388
Author(s):  
Jiyoon Han ◽  
Joonhong Park
Keyword(s):  
Intellectual Disability ◽  
Cerebral Infarction ◽  
Exome Sequencing ◽  
Developmental Delay ◽  
Growth Retardation ◽  
De Novo ◽  
Confirmatory Test ◽  
Chromosomal Microarray ◽  
Facial Dysmorphism ◽  
Coverage Analysis

The terminal 14q32 duplication has been reported often in association with other cytogenetic abnormalities, and individuals with this specific duplication showed varying degrees of developmental delay/intellectual disability (DD/ID) and growth retardation (GR), and distinct facial dysmorphisms. Herein, based on the limited cases of terminal duplication of 14q32 known to date, we present new affected siblings presenting with DD/ID, GR, and facial dysmorphism, as well as cerebral infarction caused by recurrent de novo der(14)t(14;14)(p11.2;q32.1) leading to terminal duplication of 14q32. We used coverage analysis generated via duo exome sequencing, performed chromosomal microarray (CMA) as a confirmatory test, and compared our findings with those reported previously. Coverage analysis generated via duo exome sequencing revealed a 17.2 Mb heterozygous duplication at chromosome 14q32.11-q32.33 with a Z ratio ranging between 0.5 and 1 in the proband and her elder brother. As a complementary method, CMA established a terminal duplication described as the arr[hg19]14q32.11q32.33(90,043,558_107,258,824)x3 in the proband and her elder brother; however, the parents and other siblings showed normal karyotyping and no abnormal gain or loss of CMA results. Five candidate genes, BCL11B, CCNK, YY1, DYNC1H1, and PACS2, were associated with the clinical phenotypes in our cases. Although the parents had normal chromosomes, two affected cases carrying terminal duplication of 14q32 can be explained by gonadal mosaicism. Further studies are needed to establish the association between cerebrovascular events and terminal duplication of chromosome 14q32, including investigation into the cytogenetics of patients with precise clinical descriptions.

Sign in / Sign up

Export Citation Format

Share Document